Transcatheter vs surgical valve replacement for severe bicuspid aortic stenosis
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older.
- You have severe aortic stenosis (a narrowed heart valve) and your heart team agrees a tissue valve is a good option for you.
- You've had a CT scan that shows your aortic valve is bicuspid (two flaps instead of three) and the scan is available for review.
- You have not had a heart procedure or stroke in the last 30 to 90 days, depending on the type.
- You do not have serious health problems like severe kidney disease, very low blood counts, or severe lung disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for severe aortic stenosis in people with a bicuspid aortic valve: transcatheter aortic valve replacement (TAVR, a less invasive procedure) and surgical aortic valve replacement (SAVR, open-heart surgery). The goal is to see which approach works better for this specific condition.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial compares two ways to replace a narrowed aortic heart valve in patients aged 65 to 75. It aims to find which approach—surgical valve replacement or a catheter-based procedure—works better for people in this age group.
This trial tests a new type of aortic valve replacement that can be inserted without open-heart surgery. It's designed for people with severe aortic stenosis who are not suitable for a standard operation.
This study tests a new way to replace your narrowed aortic valve without open-heart surgery, using a device called SAPIEN 3. It is designed for people with a specific valve shape (Type 0 bicuspid) who have severe symptoms.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
Hear when a new Bicuspid Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.